Navigation Links
Yu receives research funding from the Wallace H. Coulter Foundation
Date:9/18/2007

HOBOKEN, N.J. -- Stevens Institute of Technology Professor Xiaojun Yu, Ph.D., has received an Early Career Translational Research Award in Biomedical Engineering from the Wallace H. Coulter Foundation. This award will support his research titled, Novel structured nanofibrous scaffolds for bone healing.

Yu, Assistant Professor in the Department of Chemical, Biomedical and Materials Engineering at Stevens Schaefer School of Engineering and Science, is focusing his research on the treatment of bone injury in hard tissue trauma. This type of trauma creates large gaps in the bone tissue, requiring a bone grafting procedure as treatment. It has been found that polymeric nanofiber matrices have the potential to be used as bone grafts; however, due to manufacturing techniques there is restriction in the fabrication of nanofibers into complex three-dimensional (3D) structures necessary for effective treatment, resulting in mechanical properties that are not sufficient for direct bone tissue engineering applications.

Yu has proposed a way to overcome this challenge by incorporating nanofibers onto biodegradable polymeric 3D scaffolds which have optimal porosity due to its open geometrics and large surface area permitting the necessary nutrient transport and cell penetration into the scaffold for successful repair of large bone defects. As a result, biodegradable polymeric 3D scaffolds can provide sufficient mechanical properties and eventually be applied universally in the treatment of bone injuries.

Yu, principal investigator for the research, is working in conjunction with Cato T. Laurencin, M.D., Ph.D., University Professor of Orthopaedic Surgery at the University of Virginia, and Michelle Kofron, Ph.D., recent doctoral graduate of Orthopaedic Surgery at the University of Virginia.


'/>"/>

Contact: Maria Molina
mmolina@stevens.edu
201-216-5116
Stevens Institute of Technology
Source:Eurekalert

Page: 1

Related biology news :

1. DuPonts first biologically derived polymer receives global recognition
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Research on antibiotics receives historical recognition
4. Anthrax test, developed by army and CDC, receives FDA approval
5. Research team receives $7.5 million to study cassava
6. Researchers discover way to make cells in the eye sensitive to light
7. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
8. Columbia research lifts major hurdle to gene therapy for cancer
9. Researchers find how protein allows insects to detect and respond to pheromones
10. Researchers Uncover Key Step In Manufacture of Memory Protein
11. Research advances quest for HIV-1 vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 8.8% over the next decade to reach approximately $14.21 ... market estimates and forecasts for all the given segments on global ...
(Date:3/22/2017)... NEW YORK , March 21, 2017 /PRNewswire/ ... Customer Marketing Cloud used by retailers such as ... in its platform — Product Recommendations and Replenishment. Using ... to give more personalized product and replenishment recommendations ... purchases, but also on predictions of customer intent ...
Breaking Biology News(10 mins):
(Date:8/17/2017)... Village, CA (PRWEB) , ... August 17, 2017 ... ... technology for cancer research and personalized medicine, today announced the launch of a ... Kansas City, Missouri. The study’s goal is to evaluate the potential for early ...
(Date:8/16/2017)... ... 16, 2017 , ... Recent studies show that cancer cells ... specific cancers, such as breast, prostate, or lung, target vital pathways active in ... advanced prostate cancer. , This therapy limits the production and effectiveness of ...
(Date:8/16/2017)... MN (PRWEB) , ... August 16, 2017 , ... ... our third U.S. Food and Drug Administration (FDA) inspection at our Dilworth, MN ... No 483 was issued. This inspection was conducted as part of a routine ...
(Date:8/15/2017)... After spending the past two years building a state-of-the-art technology which ... offers this platform to healthcare stakeholders (hospitals, foundations, biopharma companies etc.) ... collection vis a vis their members, under their own brand. Three ... offer. ... ...
Breaking Biology Technology: